FindTrial
Sign In

The outcome of intravenous and inhalation anesthesia after pancreatic cancer resection: a retrospective study

The outcome of intravenous and inhalation anesthesia after pancreatic cancer resection: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056279
Enrollment
Unknown
Registered
2022-02-03
Start date
2022-02-02
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of anesthesia on survival after pancreatic cancer surgery

Interventions

TIVA group:N/A
INHA group:N/A

Sponsors

Department of Anesthesiology, Cancer Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients between 18 and 100 years of age, ASA grade 1 to 3, undergoing elective pancreatic cancer surgery in our hospital.

Exclusion criteria

Exclusion criteria: Patients with metastasis, emergency surgery, laparoscopic surgery, and incomplete clinical data were excluded.

Design outcomes

Primary

MeasureTime frame
overall survival, OS;—

Secondary

MeasureTime frame
diease-free survival, DFS;—

Countries

China

Contacts

Public ContactWang yu

Cancer Hospital of Harbin Medical University

86379317@qq.com+86 451 86298029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026